Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
Condition: Acromegaly Intervention: Sponsor: Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2019 Category: Research Source Type: clinical trials
Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Condition: Acromegaly Interventions: Drug: IONIS GHR-LRx; Drug: SRL Sponsor: Ionis Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials